Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.67 |
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6445718 | 1.00 | HCAR2 (0.67) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL28206307 | 0.93 | HCAR2 (0.67) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL9747274 | 0.93 | HCAR2 (0.67) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL27857610 | 0.93 | HCAR2 (0.67) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL9006147 | 0.93 | HCAR2 (0.67) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL27510969 | 0.93 | ATM (0.74) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL3689565 | 0.88 | HCAR2 (0.56) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL7780534 | 0.87 | HCAR2 (0.85) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL18209632 | 0.87 | HCAR2 (0.85) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL9318682 | 0.87 | HCAR2 (0.85) | HCAR2ATMMAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1533322-B1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST | TOHO TITANIUM CO LTD (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-9562119-B2 | Ethylene polymerization catalysts | W. R. GRACE & CO.-CONN. (US) | 2017-02-07 | — | — | US | disclosed |
| EP-2576633-A2 | ETHYLENE POLYMERIZATION CATALYSTS | BASF Corporation (US) | 2013-04-10 | — | — | EP | disclosed |
| WO-2011149656-A2 | ETHYLENE POLYMERIZATION CATALYSTS | BASF CORPORATION (US) | 2011-12-01 | — | — | WO | disclosed |
| US-20110294970-A1 | ETHYLENE POLYMERIZATION CATALYSTS | BASF CATALYSTS, LLC (US) | 2011-12-01 | — | — | US | disclosed |
| US-20050227856-A1 | Solid catalyst component for olefin polymerization and catalyst | TOHO CATALYST CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
| EP-1533322-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST | Toho Catalyst Co., Ltd. (JP) | 2005-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294970-A1 | ETHYLENE POLYMERIZATION CATALYSTS | ESR1, MSMO1, MCM5 | HCAR2 3524/4885ATM 44/4885MAPT 1278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.